Hutchinson Center A Life of Science'Tumor Paint' research of pediatric oncologist Jim Olson featured in short …Hutchinson Center A Life of ScienceThe Hutchinson Center's pioneering work in bone marrow transplantation led to the developmen…
ISOTECHNIKA PHARMA INC : 26 Nov 2012 – Isotechnika Cleared by FDA to … – 4-traders
ISOTECHNIKA PHARMA INC : 26 Nov 2012 – Isotechnika Cleared by FDA to …4-tradersThe primary endpoint of the trial will be defined as non-inferiority in biopsy proven acute rejection, or BPAR, episodes with patients receiving voclosporin for six months…
Douglas High student's artwork encouraging organ donation recognized – Reno Gazette-Journal
Douglas High student's artwork encouraging organ donation recognizedReno Gazette-JournalI combined individual images that represented what becoming an organ donor is all about,” Mora said in a statement released by CTDN. He is a student of Dougla…
UCLA Performs First 'Breathing Lung' Transplant in United States
Experimental technology could transform field of lung transplantation.
Move to amend blood donation rules doesn't go far enough, says thwarted donor – Global Toronto
Move to amend blood donation rules doesn't go far enough, says thwarted donorGlobal TorontoMove to amend blood donation rules doesn't go far enough, says thwarted donor. Jamie Hall, Edmonton Journal : Monday, November 26, 2012 11:00 AM. Blood b…
Fort Irwin contractor fights for his life – Desert Dispatch
Fort Irwin contractor fights for his lifeDesert DispatchHe is currently completing his first round of chemotherapy through Loma Linda University Medical Center. It is anticipated that he will undergo three to six rounds before a stem cell transplant is…
Snakepit owner Peak succumbs to cancer – Coeur d'Alene Press
Snakepit owner Peak succumbs to cancerCoeur d’Alene Press“Typically people with his diagnosis (multiple myeloma) live another two to five years … boy was he a fighter until the very end,” Haler said, adding that Peak had a stem cell transplant in…
Pharmaceutical Market Fails to Capture $188 Billion U.S. Revenue and $564 Billion Global Revenue Annually Due to …
Pharmaceutical Market Fails to Capture $188 Billion U.S. Revenue and $564 Billion Global Revenue Annually Due to Medication Non-Adherence
Isotechnika: FDA Oks To Begin Phase 3 Kidney Transplant Trials For Voclosporin – NASDAQ
Isotechnika: FDA Oks To Begin Phase 3 Kidney Transplant Trials For VoclosporinNASDAQThe primary endpoint of the trial will be defined as non-inferiority in biopsy proven acute rejection, or BPAR, episodes with patients receiving voclosporin for six mon…
Isotechnika: FDA Oks To Begin Phase 3 Kidney Transplant Trials For Voclosporin – RTT News
Isotechnika: FDA Oks To Begin Phase 3 Kidney Transplant Trials For VoclosporinRTT NewsThe primary endpoint of the trial will be defined as non-inferiority in biopsy proven acute rejection, or BPAR, episodes with patients receiving voclosporin for six m…